Literature DB >> 9870729

Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands.

E Kapiteijn1, C A Marijnen, A C Colenbrander, E Klein Kranenbarg, W H Steup, J H van Krieken, J C van Houwelingen, J W Leer, C J van de Velde.   

Abstract

AIMS: We carried out a population-based study of local recurrence rates in curatively resected patients with rectal cancer, diagnosed between 1988 and 1992. The first objective was to make an inventory of the overall local recurrence rate after non-standardized conventional surgery, inter-institutional recurrence rate variability, and correlations between patient- and tumour-related factors and recurrence rate. A second objective was to investigate the compliance to guidelines for post-operative radiotherapy.
METHODS: Data were obtained from the Comprehensive Cancer Centre West. The study comprised 1105 patients from 12 hospitals. Of these patients, 437 were ineligible because of missing medical records, no carcinoma, incorrect registration, no laparotomy, non-curative resection, or loss to follow-up.
RESULTS: The overall local recurrence rate was 22.5% with a range of 9-36% between the hospitals. These differences were not significant. Dukes' Astler-Coller stage, tumour location, and residual tumour were significant independent prognostic factors for the risk of local recurrence. Indications for post-operative radiotherapy were Dukes' Astler-Coller B2 and C tumours, positive surgical margins, and tumour spill. Compliance to the guidelines for radiotherapy was only 50%. However, no significant difference in recurrence rate was found between patients treated according to the guidelines and those not treated according to the guidelines.
CONCLUSION: This study shows a large variability in local recurrence rate between the participating hospitals and confirms that the risk of recurrence in primary rectal cancer is dependent on Dukes' Astler-Coller stage, tumour location and residual tumour. Furthermore, this study contributes to the discussion about the feasibility of guidelines for post-operative radiotherapy.

Entities:  

Mesh:

Year:  1998        PMID: 9870729     DOI: 10.1016/s0748-7983(98)93500-4

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  39 in total

1.  Cost of care for colorectal cancer in Ireland: a health care payer perspective.

Authors:  L Tilson; L Sharp; C Usher; C Walsh; Whyte S; A O'Ceilleachair; C Stuart; B Mehigan; M John Kennedy; P Tappenden; J Chilcott; A Staines; H Comber; M Barry
Journal:  Eur J Health Econ       Date:  2011-06-03

2.  Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.

Authors:  Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

3.  Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma.

Authors:  J Strassburg; A Lewin; K Ludwig; L Kilian; J Linke; V Loy; P Knuth; O Püttcher; U Ruehl; F Stöckmann; M Hackenthal; W Hopfenmüller; A Huppertz
Journal:  Langenbecks Arch Surg       Date:  2007-02-06       Impact factor: 3.445

Review 4.  Surgery for Locally Recurrent Rectal Cancer: Tips, Tricks, and Pitfalls.

Authors:  Satish K Warrier; Alexander G Heriot; Andrew Craig Lynch
Journal:  Clin Colon Rectal Surg       Date:  2016-06

5.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

6.  Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial.

Authors:  Valerie Francescutti; Angela Coates; Lehana Thabane; Charles H Goldsmith; Mark N Levine; Marko Simunovic
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

7.  Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma.

Authors:  E C Poulin; C M Schlachta; R Grégoire; P Seshadri; M O Cadeddu; J Mamazza
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

8.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

9.  [Problems in the treatment of upper rectal carcinoma].

Authors:  T Junginger; P Hermanek
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

10.  Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.

Authors:  Floris T J Ferenschild; Imro Dawson; Johannes H W de Wilt; Eelco J R de Graaf; Richard P R Groenendijk; Geert W M Tetteroo
Journal:  Int J Colorectal Dis       Date:  2009-06-02       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.